Impact of long-term statin therapy on postprocedural myocardial infarction in patients undergoing nonemergency percutaneous coronary intervention
J Gordin, A Haider, RV Swaminathan, LK Kim… - The American journal of …, 2012 - Elsevier
Periprocedural statin therapy has been shown to decrease the rate of myocardial infarctions
(MIs) after percutaneous coronary intervention (PCI). However, the impact of long-term statin …
(MIs) after percutaneous coronary intervention (PCI). However, the impact of long-term statin …
Comparison of alternate-day atorvastatin treatment to daily treatment in maintaining LDL-cholesterol targets in patients with variable coronary risk profile
3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitory activity of atorvastatin lasts upto
20–30 hours. This study aimed at comparing the maintenance of National Cholesterol …
20–30 hours. This study aimed at comparing the maintenance of National Cholesterol …
Influence of atorvastatin on serum amyloid A-low density lipoprotein complex in hypercholesterolemic patients
K Kazuhiko, Y Toshiyuki, M Michiaki, I Shun… - Pharmacological …, 2012 - Elsevier
The complex of serum amyloid A (SAA) and low-density lipoprotein (LDL), SAA-LDL, is
considered a new and unique marker of oxidatively-modified LDL particles, which is …
considered a new and unique marker of oxidatively-modified LDL particles, which is …